Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03277352
Title INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Incyte Biosciences International Sàrl
Indications

Advanced Solid Tumor

renal cell carcinoma

transitional cell carcinoma

melanoma

Therapies

Epacadostat + INCAGN01876 + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
The Angeles Clinic and Research Institute Los Angeles California 90025 United States Details
Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field